Bhaskar Anand

CIK: 0001890784

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SMMT

Summit Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

SMMT
Summit Therapeutics Inc.
Oct 8, 2026
Award(A)
Direct
100K shares-
SMMT
Summit Therapeutics Inc.
Jan 8, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
SMMT
Summit Therapeutics Inc.
Oct 21, 2025
Award(A)
Direct
26.7K shares at avg. $18.74$500K
SMMT
Summit Therapeutics Inc.
Sep 18, 2025
Award(A)
Stock Option (right to buy)
Direct
50K shares-
SMMT
Summit Therapeutics Inc.
Apr 29, 2025
Award(A)
Stock Option (right to buy)
Direct
600K shares-
SMMT
Summit Therapeutics Inc.
Apr 29, 2025
Award(A)
Stock Option (right to buy)
Direct
75K shares-
SMMT
Summit Therapeutics Inc.
Jan 12, 2025
Award(A)
Stock Option (right to buy)
Direct
75K shares-
SMMT
Summit Therapeutics Inc.
Sep 11, 2024
Award(A)
Direct
22K shares at avg. $22.70$500K

		Type	Shares	Price		Ownership
Oct 8, 2026	SMMT Summit Therapeutics Inc.	Award(A)	100,000	-	$0	Direct
Jan 8, 2026	SMMT Summit Therapeutics Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Oct 21, 2025	SMMT Summit Therapeutics Inc.	Award(A)	26,680	$18.74	$499,983	Direct
Sep 18, 2025	SMMT Summit Therapeutics Inc.	Award(A) Stock Option (right to buy)	50,000	-	-	Direct
Apr 29, 2025	SMMT Summit Therapeutics Inc.	Award(A) Stock Option (right to buy)	600,000	-	-	Direct
Apr 29, 2025	SMMT Summit Therapeutics Inc.	Award(A) Stock Option (right to buy)	75,000	-	-	Direct
Jan 12, 2025	SMMT Summit Therapeutics Inc.	Award(A) Stock Option (right to buy)	75,000	-	-	Direct
Sep 11, 2024	SMMT Summit Therapeutics Inc.	Award(A)	22,026	$22.70	$499,990	Direct

1-8 of 8 transactions

About Anand Bhaskar

Anand Bhaskar (SEC CIK 0001890784) files insider reports with the SEC as Chief Accounting Officer of Summit Therapeutics Inc. (SMMT).

Signal8 holds 7 ownership filings by Anand Bhaskar, all Form 4s, filed between Sep 13, 2024 and Oct 14, 2026. Those filings report 8 transactions, from Sep 11, 2024 to Oct 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Anand Bhaskar's filings is in MIAMI, FL.

Recent filings by Anand Bhaskar

Oct 8, 2026: Grant or award of SMMT shares (Form 4, code A).
Jan 8, 2026: Grant or award of SMMT derivative securities (Form 4, code A).
Oct 21, 2025: Grant or award of SMMT shares (Form 4, code A).
Sep 18, 2025: Grant or award of SMMT derivative securities (Form 4, code A).
Apr 29, 2025: Grants or awards of SMMT derivative securities (2 lines, Form 4, code A).

Other insiders filing for Summit Therapeutics Inc. (SMMT)

Zanganeh Mahkam, Co-Chief Executive Officer
DUGGAN ROBERT W, Co-Chief Executive Officer
Soni Manmeet Singh, COO and CFO
Booth Robert F., Director
Xia Yu, Director
Huber Jeff, Director

How to read Form 4 transaction codes